Multiplexed CRISPR-based microfluidic platform for clinical testing of respiratory viruses and identification of SARS-CoV-2 variants
Nicole L. Welch, Meilin Zhu, Catherine Hua et al. · Nature Medicine · 2022
The coronavirus disease 2019 (COVID-19) pandemic has demonstrated a clear need for high-throughput, multiplexed and sensitive assays for detecting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and other respiratory viruses and their emerging variants. Here, we present a cost-effective virus and variant detection platform, called microfluidic Combinatorial Arrayed Reactions for Multiplexed Evaluation of Nucleic acids (mCARMEN), which combines CRISPR-based diagnostics and microfluidics with a streamlined workflow for clinical use. We developed the mCARMEN respiratory virus panel to test for up to 21 viruses, including SARS-CoV-2, other coronaviruses and both influenza strains, and demonstrated its diagnostic-grade performance on 525 patient specimens in an academic setting and 166 specimens in a clinical setting. We further developed an mCARMEN panel to enable the identification of 6 SARS-CoV-2 variant lineages, including Delta and Omicron, and evaluated it on 2,088 patient specimens with near-perfect concordance to sequencing-based variant classification. Lastly, we implemented a combined Cas13 and Cas12 approach that enables quantitative measurement of SARS-CoV-2 and influenza A viral copies in samples. The mCARMEN platform enables high-throughput surveillance of multiple viruses and variants simultaneously, enabling rapid detection of SARS-CoV-2 variants.
Cited by 304 works. doi:10.1038/s41591-022-01734-1 Open-access PDF
Authors
- Nicole L. Welch
- Meilin Zhu
- Catherine Hua
- Juliane Weller
- Marzieh Ezzaty Mirhashemi
- Tien G. Nguyen
- Sreekar Mantena
- Matthew R. Bauer
- Bennett M. Shaw
- Cheri M. Ackerman
- Sri Gowtham Thakku
- Megan W. Tse
- Jared Kehe
- Marie-Martine Uwera
- Jacqueline S. Eversley
- Derek A. Bielwaski
- Graham McGrath
- Joseph Braidt
- Jeremy Johnson
- Felecia E. Cerrato
References
- MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability
- SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients
- Virological assessment of hospitalized patients with COVID-2019
- CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity
- Nucleic acid detection with CRISPR-Cas13a/C2c2
- SARS-CoV-2 variants, spike mutations and immune escape
- Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa
- Real-time PCR in virology
- CRISPR–Cas12-based detection of SARS-CoV-2
- Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6